Lv6
2838 积分 2020-07-27 加入
Modulation of the Fce Receptor I Signaling by Tyrosine Kinase Inhibitors: Search for Therapeutic Targets of Inflammatory and Allergy Diseases
7天前
已完结
Chronic Spontaneous Urticaria A Review
7天前
已完结
Immune Thrombocytopenia
29天前
已完结
Next-generation JAK inhibitors in the treatment of myeloproliferative neoplasms
1个月前
已完结
CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons
1个月前
已完结
New Binding Sites for JAK2 Inhibition in Myeloproliferative Neoplasms: Structural Insights, Therapeutic Potential, and Future Directions
1个月前
已完结
BTK inhibitors and next-generation BTK-targeted therapeutics for B-cell malignancies
2个月前
已完结
Involvement of Btk in Cardiovascular Disease and Its Therapeutic Targeting
2个月前
已完结
SOHO State of the Art Updates and Next Questions: Updates on BTK Inhibitors for the Treatment of Chronic Lymphocytic Leukemia
2个月前
已完结
JAK2V617F negatively regulates p53 stabilization by enhancing MDM2 via La expression in myeloproliferative neoplasms
2个月前
已完结
皖公网安备34019202002308
